

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 9.27512625 |
| 2 | replicative senescence (GO:0090399) | 8.23651383 |
| 3 | eosinophil chemotaxis (GO:0048245) | 7.97567027 |
| 4 | cellular response to ethanol (GO:0071361) | 7.79357634 |
| 5 | protein prenylation (GO:0018342) | 7.35955677 |
| 6 | prenylation (GO:0097354) | 7.35955677 |
| 7 | regulation of lymphocyte chemotaxis (GO:1901623) | 7.15945364 |
| 8 | eosinophil migration (GO:0072677) | 7.14081458 |
| 9 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 6.89719093 |
| 10 | hematopoietic stem cell proliferation (GO:0071425) | 6.89263408 |
| 11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 6.69174280 |
| 12 | activation of protein kinase A activity (GO:0034199) | 6.08170428 |
| 13 | cAMP biosynthetic process (GO:0006171) | 5.96344466 |
| 14 | post-anal tail morphogenesis (GO:0036342) | 5.89819461 |
| 15 | regulation of prostaglandin secretion (GO:0032306) | 5.79896676 |
| 16 | regulation of DNA damage checkpoint (GO:2000001) | 5.61520848 |
| 17 | sulfation (GO:0051923) | 5.50475762 |
| 18 | viral mRNA export from host cell nucleus (GO:0046784) | 5.46832645 |
| 19 | positive regulation of prostaglandin secretion (GO:0032308) | 4.97934451 |
| 20 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.87515509 |
| 21 | osteoclast differentiation (GO:0030316) | 4.67116248 |
| 22 | monocyte chemotaxis (GO:0002548) | 4.34641744 |
| 23 | spleen development (GO:0048536) | 4.33068669 |
| 24 | cell adhesion mediated by integrin (GO:0033627) | 4.32337554 |
| 25 | membrane protein intracellular domain proteolysis (GO:0031293) | 4.28881715 |
| 26 | regulation of macrophage chemotaxis (GO:0010758) | 4.24230169 |
| 27 | wound healing, spreading of epidermal cells (GO:0035313) | 4.22112131 |
| 28 | negative regulation of catenin import into nucleus (GO:0035414) | 4.07584493 |
| 29 | regulation of endothelial cell differentiation (GO:0045601) | 3.94662365 |
| 30 | cellular extravasation (GO:0045123) | 3.89554730 |
| 31 | neutrophil mediated immunity (GO:0002446) | 3.72629193 |
| 32 | membrane protein ectodomain proteolysis (GO:0006509) | 3.63471338 |
| 33 | regulation of mononuclear cell migration (GO:0071675) | 3.54942085 |
| 34 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.54464862 |
| 35 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.54464862 |
| 36 | positive regulation of lymphocyte migration (GO:2000403) | 3.46416941 |
| 37 | cellular response to exogenous dsRNA (GO:0071360) | 3.28537626 |
| 38 | segmentation (GO:0035282) | 3.27158113 |
| 39 | regulation of icosanoid secretion (GO:0032303) | 3.26262063 |
| 40 | positive regulation of RNA splicing (GO:0033120) | 3.24912056 |
| 41 | regulation of lymphocyte migration (GO:2000401) | 3.22427408 |
| 42 | response to lipoprotein particle (GO:0055094) | 3.21926232 |
| 43 | cellular response to interleukin-1 (GO:0071347) | 3.20047018 |
| 44 | somitogenesis (GO:0001756) | 3.17562277 |
| 45 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.14606061 |
| 46 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.14606061 |
| 47 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.12682689 |
| 48 | germinal center formation (GO:0002467) | 3.06943808 |
| 49 | tryptophan metabolic process (GO:0006568) | 3.06739669 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.06540843 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.06540843 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.06540843 |
| 53 | positive regulation of icosanoid secretion (GO:0032305) | 3.06224368 |
| 54 | positive regulation of T cell chemotaxis (GO:0010820) | 3.03954083 |
| 55 | regulation of T cell chemotaxis (GO:0010819) | 3.03954083 |
| 56 | regulation of skeletal muscle contraction (GO:0014819) | 3.03718480 |
| 57 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.03528656 |
| 58 | thymus development (GO:0048538) | 3.00338761 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99771870 |
| 60 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.95244482 |
| 61 | cyclic purine nucleotide metabolic process (GO:0052652) | 2.93477723 |
| 62 | kynurenine metabolic process (GO:0070189) | 2.91930443 |
| 63 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.91283284 |
| 64 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.91032929 |
| 65 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.91032929 |
| 66 | cAMP metabolic process (GO:0046058) | 2.90971993 |
| 67 | cyclic nucleotide biosynthetic process (GO:0009190) | 2.83526859 |
| 68 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.78133470 |
| 69 | NADH dehydrogenase complex assembly (GO:0010257) | 2.78133470 |
| 70 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.78133470 |
| 71 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.76259967 |
| 72 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.74929334 |
| 73 | innate immune response in mucosa (GO:0002227) | 2.74761270 |
| 74 | interferon-gamma secretion (GO:0072643) | 2.71281330 |
| 75 | righting reflex (GO:0060013) | 2.69639499 |
| 76 | T cell mediated immunity (GO:0002456) | 2.67476732 |
| 77 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.64859618 |
| 78 | positive regulation of osteoclast differentiation (GO:0045672) | 2.64097071 |
| 79 | myeloid leukocyte mediated immunity (GO:0002444) | 2.63074573 |
| 80 | membrane protein proteolysis (GO:0033619) | 2.62935733 |
| 81 | wound healing, spreading of cells (GO:0044319) | 2.62177171 |
| 82 | positive regulation of fatty acid transport (GO:2000193) | 2.61373683 |
| 83 | vitamin A metabolic process (GO:0006776) | 2.55660919 |
| 84 | granulocyte chemotaxis (GO:0071621) | 2.54625890 |
| 85 | dendritic spine morphogenesis (GO:0060997) | 2.54579985 |
| 86 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.53964199 |
| 87 | detection of calcium ion (GO:0005513) | 2.53924717 |
| 88 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.53751034 |
| 89 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.53744859 |
| 90 | negative regulation of fibrinolysis (GO:0051918) | 2.49443714 |
| 91 | granulocyte migration (GO:0097530) | 2.44499372 |
| 92 | negative regulation of interleukin-17 production (GO:0032700) | 2.43869995 |
| 93 | protein localization to synapse (GO:0035418) | 2.43487609 |
| 94 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 2.40706585 |
| 95 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.40666344 |
| 96 | lymphangiogenesis (GO:0001946) | 2.40115404 |
| 97 | cardiac muscle hypertrophy (GO:0003300) | 2.39841566 |
| 98 | cellular biogenic amine catabolic process (GO:0042402) | 2.39571403 |
| 99 | amine catabolic process (GO:0009310) | 2.39571403 |
| 100 | regulation of somitogenesis (GO:0014807) | 14.4533859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.11962007 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.83299066 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.03102896 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.48556106 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.31826155 |
| 6 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.28326611 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24534699 |
| 8 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.23307878 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 13.2118763 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 10.0209429 |
| 11 | TP53_16413492_ChIP-PET_HCT116_Human | 1.84313147 |
| 12 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.73310747 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69540997 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63542575 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47399072 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38412297 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37415146 |
| 18 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36148229 |
| 19 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.35826569 |
| 20 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31317990 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.29606959 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26745944 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19403946 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19401602 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.18688981 |
| 26 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17020838 |
| 27 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.12889270 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11754240 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10817473 |
| 30 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.09640807 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06542093 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02606599 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01275223 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99974740 |
| 35 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98603918 |
| 36 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.96289546 |
| 37 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95803782 |
| 38 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94955330 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94475855 |
| 40 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92225194 |
| 41 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.91983305 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 0.91069927 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90945715 |
| 44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89151963 |
| 45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88175029 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87660337 |
| 47 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.87393074 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87196295 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85798078 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85505149 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85505149 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83884320 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83545159 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82235878 |
| 55 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82022648 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81541332 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81379572 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80917759 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79915922 |
| 60 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.79053107 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.76872744 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.76495411 |
| 63 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76160722 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74980179 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74323575 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74091577 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74091577 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 0.73777143 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.73743050 |
| 70 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.73660427 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.72645889 |
| 72 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.72005732 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.71534348 |
| 74 | KDM2B_26808549_Chip-Seq_REH_Human | 0.70873502 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.70185874 |
| 76 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.69765117 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.69764177 |
| 78 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.69383601 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.69383601 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.68496486 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68292460 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67806863 |
| 83 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.67201797 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.67021651 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66505722 |
| 86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.65373297 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.64993955 |
| 88 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.63835832 |
| 89 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.60742383 |
| 90 | RXR_22108803_ChIP-Seq_LS180_Human | 0.60662375 |
| 91 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.60429680 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60058172 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.59736958 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.59716165 |
| 95 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.59590959 |
| 96 | JUN_21703547_ChIP-Seq_K562_Human | 0.59495340 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.59366469 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.59236600 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.58963596 |
| 100 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.58471354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.94373432 |
| 2 | MP0009764_decreased_sensitivity_to | 4.45309907 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 4.30779475 |
| 4 | MP0005084_abnormal_gallbladder_morpholo | 3.93215723 |
| 5 | MP0003221_abnormal_cardiomyocyte_apopto | 3.13087668 |
| 6 | MP0005451_abnormal_body_composition | 3.04495969 |
| 7 | MP0000371_diluted_coat_color | 3.02616293 |
| 8 | MP0003252_abnormal_bile_duct | 2.86487003 |
| 9 | MP0009840_abnormal_foam_cell | 2.72466177 |
| 10 | MP0004233_abnormal_muscle_weight | 2.66180754 |
| 11 | MP0002928_abnormal_bile_duct | 2.57238050 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.51701970 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.16508260 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.09842275 |
| 15 | MP0003183_abnormal_peptide_metabolism | 1.98409394 |
| 16 | MP0008872_abnormal_physiological_respon | 1.78609425 |
| 17 | MP0002090_abnormal_vision | 1.78528284 |
| 18 | MP0000750_abnormal_muscle_regeneration | 1.78044768 |
| 19 | MP0003828_pulmonary_edema | 1.77026582 |
| 20 | MP0004134_abnormal_chest_morphology | 1.72717666 |
| 21 | MP0005409_darkened_coat_color | 1.67594758 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.64204782 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.63857533 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 1.59970707 |
| 25 | MP0002075_abnormal_coat/hair_pigmentati | 1.55999799 |
| 26 | MP0004270_analgesia | 1.53290570 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.51856508 |
| 28 | MP0008770_decreased_survivor_rate | 1.51765198 |
| 29 | MP0002932_abnormal_joint_morphology | 1.50502662 |
| 30 | MP0004272_abnormal_basement_membrane | 1.48477028 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.42723229 |
| 32 | MP0005083_abnormal_biliary_tract | 1.40666493 |
| 33 | MP0003646_muscle_fatigue | 1.36375302 |
| 34 | MP0008004_abnormal_stomach_pH | 1.34941275 |
| 35 | MP0000343_altered_response_to | 1.34713466 |
| 36 | MP0005187_abnormal_penis_morphology | 1.33791909 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.33160416 |
| 38 | MP0005410_abnormal_fertilization | 1.25959379 |
| 39 | MP0002009_preneoplasia | 1.25610070 |
| 40 | MP0002160_abnormal_reproductive_system | 1.25383997 |
| 41 | MP0004130_abnormal_muscle_cell | 1.23045872 |
| 42 | MP0000747_muscle_weakness | 1.21373360 |
| 43 | MP0001270_distended_abdomen | 1.18006944 |
| 44 | MP0001186_pigmentation_phenotype | 1.17816886 |
| 45 | MP0000163_abnormal_cartilage_morphology | 1.15597219 |
| 46 | MP0004484_altered_response_of | 1.14759679 |
| 47 | MP0004885_abnormal_endolymph | 1.10127284 |
| 48 | MP0002127_abnormal_cardiovascular_syste | 1.09835883 |
| 49 | MP0000678_abnormal_parathyroid_gland | 1.08921189 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.08730699 |
| 51 | MP0000749_muscle_degeneration | 1.08431677 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.06171887 |
| 53 | MP0008260_abnormal_autophagy | 1.03745153 |
| 54 | MP0002419_abnormal_innate_immunity | 1.03467915 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 1.01522137 |
| 56 | MP0003567_abnormal_fetal_cardiomyocyte | 1.00938423 |
| 57 | MP0002332_abnormal_exercise_endurance | 0.97008183 |
| 58 | MP0003315_abnormal_perineum_morphology | 0.95816885 |
| 59 | MP0002095_abnormal_skin_pigmentation | 0.91639833 |
| 60 | MP0000613_abnormal_salivary_gland | 0.91583477 |
| 61 | MP0009115_abnormal_fat_cell | 0.90667320 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 0.88860049 |
| 63 | MP0005385_cardiovascular_system_phenoty | 0.88860049 |
| 64 | MP0009250_abnormal_appendicular_skeleto | 0.87987559 |
| 65 | MP0003633_abnormal_nervous_system | 0.87316625 |
| 66 | MP0004215_abnormal_myocardial_fiber | 0.87224904 |
| 67 | MP0003011_delayed_dark_adaptation | 0.84483585 |
| 68 | MP0003436_decreased_susceptibility_to | 0.83727335 |
| 69 | MP0000049_abnormal_middle_ear | 0.82588601 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.82085355 |
| 71 | MP0006138_congestive_heart_failure | 0.81904845 |
| 72 | MP0000609_abnormal_liver_physiology | 0.81565737 |
| 73 | MP0004133_heterotaxia | 0.81477039 |
| 74 | MP0005166_decreased_susceptibility_to | 0.81195503 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.81148005 |
| 76 | MP0002111_abnormal_tail_morphology | 0.81140494 |
| 77 | MP0000733_abnormal_muscle_development | 0.80355559 |
| 78 | MP0003303_peritoneal_inflammation | 0.79693789 |
| 79 | MP0002972_abnormal_cardiac_muscle | 0.79075844 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 0.77867664 |
| 81 | MP0009046_muscle_twitch | 0.76771650 |
| 82 | MP0005389_reproductive_system_phenotype | 0.73185312 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.72093550 |
| 84 | MP0001324_abnormal_eye_pigmentation | 0.70510097 |
| 85 | MP0006276_abnormal_autonomic_nervous | 0.67689171 |
| 86 | MP0003091_abnormal_cell_migration | 0.67277594 |
| 87 | MP0002163_abnormal_gland_morphology | 0.66842754 |
| 88 | MP0004197_abnormal_fetal_growth/weight/ | 0.66703137 |
| 89 | MP0002452_abnormal_antigen_presenting | 0.65730199 |
| 90 | MP0005164_abnormal_response_to | 0.65164477 |
| 91 | MP0003959_abnormal_lean_body | 0.64035193 |
| 92 | MP0010234_abnormal_vibrissa_follicle | 0.63957809 |
| 93 | MP0002139_abnormal_hepatobiliary_system | 0.62938738 |
| 94 | MP0001175_abnormal_lung_morphology | 0.62454046 |
| 95 | MP0005423_abnormal_somatic_nervous | 0.62385473 |
| 96 | MP0002106_abnormal_muscle_physiology | 0.61613040 |
| 97 | MP0005334_abnormal_fat_pad | 0.61581869 |
| 98 | MP0002113_abnormal_skeleton_development | 0.60723899 |
| 99 | MP0003631_nervous_system_phenotype | 0.58230366 |
| 100 | MP0001191_abnormal_skin_condition | 0.58173051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hemiplegia (HP:0002301) | 6.11331047 |
| 2 | Myelomeningocele (HP:0002475) | 5.25009565 |
| 3 | Abnormality of the intervertebral disk (HP:0005108) | 5.09899006 |
| 4 | Abnormality of the odontoid process (HP:0003310) | 5.01518528 |
| 5 | Rough bone trabeculation (HP:0100670) | 4.88227478 |
| 6 | Tongue fasciculations (HP:0001308) | 4.56292456 |
| 7 | Slow saccadic eye movements (HP:0000514) | 4.47098011 |
| 8 | Muscle fibrillation (HP:0010546) | 4.46109512 |
| 9 | Short femoral neck (HP:0100864) | 4.44414587 |
| 10 | Premature graying of hair (HP:0002216) | 4.27397794 |
| 11 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.92415553 |
| 12 | Pathologic fracture (HP:0002756) | 3.89518865 |
| 13 | Abnormal trabecular bone morphology (HP:0100671) | 3.86684273 |
| 14 | Vertebral fusion (HP:0002948) | 3.81433782 |
| 15 | Hemivertebrae (HP:0002937) | 3.57176667 |
| 16 | Prominent occiput (HP:0000269) | 3.27629142 |
| 17 | Aplasia/hypoplasia of the femur (HP:0005613) | 3.19975145 |
| 18 | Oligodontia (HP:0000677) | 3.07213830 |
| 19 | Impaired smooth pursuit (HP:0007772) | 3.02157994 |
| 20 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.97706157 |
| 21 | Meningocele (HP:0002435) | 2.91863865 |
| 22 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.74736556 |
| 23 | Bone marrow hypocellularity (HP:0005528) | 2.64071991 |
| 24 | Duplicated collecting system (HP:0000081) | 2.60121363 |
| 25 | Abnormality of the renal collecting system (HP:0004742) | 2.52752909 |
| 26 | Spina bifida occulta (HP:0003298) | 2.35042413 |
| 27 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.31905251 |
| 28 | Deformed sella turcica (HP:0002681) | 2.26880924 |
| 29 | Ankyloglossia (HP:0010296) | 2.24639432 |
| 30 | Cellular immunodeficiency (HP:0005374) | 2.19889782 |
| 31 | Persistence of primary teeth (HP:0006335) | 2.18183713 |
| 32 | Abnormality of the lumbar spine (HP:0100712) | 2.16040765 |
| 33 | Calf muscle hypertrophy (HP:0008981) | 2.08311928 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.03590940 |
| 35 | Amelogenesis imperfecta (HP:0000705) | 2.02968159 |
| 36 | Oral leukoplakia (HP:0002745) | 12.0842314 |
| 37 | Anomalous pulmonary venous return (HP:0010772) | 12.0076657 |
| 38 | Abnormality of the pulmonary veins (HP:0011718) | 10.6311048 |
| 39 | Sparse lateral eyebrow (HP:0005338) | 1.98140880 |
| 40 | Adactyly (HP:0009776) | 1.97965309 |
| 41 | Hamartoma of the eye (HP:0010568) | 1.95639445 |
| 42 | Anonychia (HP:0001798) | 1.94419694 |
| 43 | Blepharitis (HP:0000498) | 1.93716136 |
| 44 | Broad forehead (HP:0000337) | 1.90177188 |
| 45 | Drooling (HP:0002307) | 1.89625898 |
| 46 | Aplasia cutis congenita (HP:0001057) | 1.88327153 |
| 47 | J-shaped sella turcica (HP:0002680) | 1.88178015 |
| 48 | Aortic regurgitation (HP:0001659) | 1.86250311 |
| 49 | Short thorax (HP:0010306) | 1.86001906 |
| 50 | Ureteral duplication (HP:0000073) | 1.82414923 |
| 51 | Aseptic necrosis (HP:0010885) | 1.81300043 |
| 52 | Osteomalacia (HP:0002749) | 1.80449268 |
| 53 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.79777843 |
| 54 | Abnormality of the nasal septum (HP:0000419) | 1.79527099 |
| 55 | Neoplasm of the pancreas (HP:0002894) | 1.79029864 |
| 56 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.78443239 |
| 57 | Abnormality of the frontal sinuses (HP:0002687) | 1.78400914 |
| 58 | Abnormal pancreas size (HP:0012094) | 1.77309883 |
| 59 | Hyporeflexia of lower limbs (HP:0002600) | 1.76071381 |
| 60 | Broad ribs (HP:0000885) | 1.74984198 |
| 61 | Syringomyelia (HP:0003396) | 1.74477603 |
| 62 | Spinal cord lesions (HP:0100561) | 1.74477603 |
| 63 | Genetic anticipation (HP:0003743) | 1.73674933 |
| 64 | Ectopic kidney (HP:0000086) | 1.72123961 |
| 65 | Upper motor neuron abnormality (HP:0002127) | 1.71130357 |
| 66 | Neoplasm of the heart (HP:0100544) | 1.70327302 |
| 67 | Difficulty climbing stairs (HP:0003551) | 1.69617072 |
| 68 | Excessive salivation (HP:0003781) | 1.68495620 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 1.67132254 |
| 70 | Pelvic girdle muscle weakness (HP:0003749) | 1.66291150 |
| 71 | Hypoplastic pelvis (HP:0008839) | 1.64876309 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.63081601 |
| 73 | Postnatal growth retardation (HP:0008897) | 1.62659351 |
| 74 | Abnormality of DNA repair (HP:0003254) | 1.59462971 |
| 75 | Abnormality of saccadic eye movements (HP:0000570) | 1.58177187 |
| 76 | Postural tremor (HP:0002174) | 1.56577989 |
| 77 | Abnormality of the pons (HP:0007361) | 1.55786498 |
| 78 | Long toe (HP:0010511) | 1.55713504 |
| 79 | Shoulder girdle muscle weakness (HP:0003547) | 1.55710345 |
| 80 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.55112632 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 1.53013561 |
| 82 | Hematochezia (HP:0002573) | 1.52617313 |
| 83 | Generalized hypopigmentation of hair (HP:0011358) | 1.50538148 |
| 84 | Death in childhood (HP:0003819) | 1.49083896 |
| 85 | Tracheoesophageal fistula (HP:0002575) | 1.48663318 |
| 86 | Limb-girdle muscle atrophy (HP:0003797) | 1.46528977 |
| 87 | Abnormality of the sella turcica (HP:0002679) | 1.45989866 |
| 88 | Decreased circulating renin level (HP:0003351) | 1.43593593 |
| 89 | Periauricular skin pits (HP:0100277) | 1.43206573 |
| 90 | Preauricular pit (HP:0004467) | 1.43206573 |
| 91 | Rectal prolapse (HP:0002035) | 1.43152932 |
| 92 | Abnormality of the preputium (HP:0100587) | 1.42448287 |
| 93 | Short nail (HP:0001799) | 1.37100620 |
| 94 | Thickened calvaria (HP:0002684) | 1.36923885 |
| 95 | Conjunctival hamartoma (HP:0100780) | 1.36848043 |
| 96 | Small hand (HP:0200055) | 1.36685778 |
| 97 | Skin pits (HP:0100276) | 1.36578187 |
| 98 | Osteoporosis (HP:0000939) | 1.36065787 |
| 99 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.35438348 |
| 100 | Short 4th metacarpal (HP:0010044) | 1.35438348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 9.97199464 |
| 2 | IRAK3 | 6.72812991 |
| 3 | TLK1 | 4.34006630 |
| 4 | MAP2K7 | 3.91089989 |
| 5 | MAP3K4 | 3.87929778 |
| 6 | ZAK | 3.48762097 |
| 7 | MAP2K4 | 2.61487060 |
| 8 | PKN2 | 2.53524476 |
| 9 | CAMK1D | 2.17863744 |
| 10 | STK24 | 1.99779930 |
| 11 | CAMKK2 | 1.77158799 |
| 12 | CAMK1G | 1.57789499 |
| 13 | FLT3 | 1.35046782 |
| 14 | NEK9 | 1.34182319 |
| 15 | STK38L | 1.17938642 |
| 16 | VRK1 | 1.17091856 |
| 17 | RET | 1.13143786 |
| 18 | MAP3K2 | 1.06203148 |
| 19 | TGFBR2 | 1.01724903 |
| 20 | STK4 | 0.92883704 |
| 21 | MAP3K6 | 0.90992503 |
| 22 | CAMK4 | 0.90125034 |
| 23 | SYK | 0.82845347 |
| 24 | CSK | 0.81312607 |
| 25 | GRK7 | 0.77050961 |
| 26 | TRPM7 | 0.74373029 |
| 27 | KSR2 | 0.66594273 |
| 28 | SGK2 | 0.64628085 |
| 29 | PLK2 | 0.62767824 |
| 30 | PKN1 | 0.62433564 |
| 31 | PIM1 | 0.61231249 |
| 32 | RPS6KA5 | 0.61072993 |
| 33 | SGK3 | 0.60866202 |
| 34 | MAP3K5 | 0.59767164 |
| 35 | WNK1 | 0.55022724 |
| 36 | CDK9 | 0.54767042 |
| 37 | AKT3 | 0.54287816 |
| 38 | STK3 | 0.52116678 |
| 39 | TAF1 | 0.49918453 |
| 40 | LYN | 0.49606976 |
| 41 | FGFR1 | 0.47756882 |
| 42 | DAPK3 | 0.46759845 |
| 43 | ADRBK2 | 0.45445660 |
| 44 | MOS | 0.45356376 |
| 45 | PRKCI | 0.43048326 |
| 46 | CSNK1A1L | 0.40301715 |
| 47 | GRK1 | 0.40096874 |
| 48 | TNIK | 0.39370964 |
| 49 | MAP3K9 | 0.39236887 |
| 50 | RPS6KA2 | 0.37834559 |
| 51 | PIK3CG | 0.37150946 |
| 52 | SCYL2 | 0.36950804 |
| 53 | ERBB4 | 0.36856758 |
| 54 | MAP3K8 | 0.35748791 |
| 55 | MAP2K3 | 0.35360346 |
| 56 | SGK494 | 0.35341386 |
| 57 | SGK223 | 0.35341386 |
| 58 | BMPR2 | 0.35100409 |
| 59 | PRKAA1 | 0.34712157 |
| 60 | AURKA | 0.33149667 |
| 61 | PDGFRB | 0.32801552 |
| 62 | RPS6KA6 | 0.32655267 |
| 63 | KSR1 | 0.31822005 |
| 64 | MAP3K14 | 0.30559891 |
| 65 | PDK1 | 0.30053329 |
| 66 | JAK2 | 0.30009336 |
| 67 | ZAP70 | 0.29528508 |
| 68 | EGFR | 0.29109091 |
| 69 | EEF2K | 0.29092182 |
| 70 | RPS6KC1 | 0.28400627 |
| 71 | RPS6KL1 | 0.28400627 |
| 72 | OBSCN | 0.27660845 |
| 73 | TAOK3 | 0.27227655 |
| 74 | AKT2 | 0.26462538 |
| 75 | MKNK2 | 0.25889573 |
| 76 | MELK | 0.23020334 |
| 77 | MAPK11 | 0.22707759 |
| 78 | DAPK2 | 0.21864074 |
| 79 | MAPK4 | 0.20321483 |
| 80 | FGFR3 | 0.19825131 |
| 81 | CAMKK1 | 0.19234846 |
| 82 | CSNK1G3 | 0.18864711 |
| 83 | INSR | 0.17975489 |
| 84 | PDPK1 | 0.17888560 |
| 85 | RAF1 | 0.17638707 |
| 86 | FYN | 0.16911160 |
| 87 | RPS6KB1 | 0.15101457 |
| 88 | RIPK4 | 0.14966972 |
| 89 | ERBB2 | 0.14822690 |
| 90 | PRKAA2 | 0.14322834 |
| 91 | HIPK2 | 0.14049810 |
| 92 | EIF2AK3 | 0.13104579 |
| 93 | CAMK1 | 0.11877510 |
| 94 | LATS1 | 0.10930172 |
| 95 | CSNK1G2 | 0.10845506 |
| 96 | CSNK1G1 | 0.10115023 |
| 97 | CDK6 | 0.10063238 |
| 98 | IGF1R | 0.09213071 |
| 99 | ABL2 | 0.08891814 |
| 100 | CAMK2A | 0.08696931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 5.68769668 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.03490931 |
| 3 | Alcoholism_Homo sapiens_hsa05034 | 3.58625328 |
| 4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.15545626 |
| 5 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 2.12276743 |
| 6 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.80922853 |
| 7 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.79647293 |
| 8 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.70052311 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65824989 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63098088 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56763372 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56704119 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 1.49490351 |
| 14 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.48705864 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45403158 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45213879 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.43233297 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35382434 |
| 19 | Bladder cancer_Homo sapiens_hsa05219 | 1.31787436 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31715966 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30416925 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.30131153 |
| 23 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.25045520 |
| 24 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23854361 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23836435 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23482163 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21935301 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19416611 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.19383839 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16018485 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12017642 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11011671 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09521703 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06291041 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.05695580 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 1.05639547 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01223743 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98765353 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93524488 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92593825 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92555003 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92107406 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91012629 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90618687 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90275194 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89414943 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89244402 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.84100562 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82538681 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81739896 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81252197 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79978524 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78874396 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78244510 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77283277 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.76374267 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.75966985 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75893565 |
| 59 | Melanogenesis_Homo sapiens_hsa04916 | 0.74907940 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.74782511 |
| 61 | GABAergic synapse_Homo sapiens_hsa04727 | 0.74117076 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74008872 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70949753 |
| 64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70571578 |
| 65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70103210 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70089641 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69616207 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68512813 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66990250 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65644970 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.65302521 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64109701 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63658706 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63589442 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62842296 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61469772 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.61421883 |
| 78 | Taste transduction_Homo sapiens_hsa04742 | 0.61301147 |
| 79 | Melanoma_Homo sapiens_hsa05218 | 0.60635837 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59912656 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58663828 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58386431 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57056350 |
| 84 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52304529 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51437579 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50176635 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50139401 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50058830 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.45899817 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45083031 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44418449 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43463018 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42056593 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.41925779 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41748914 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38934962 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38859618 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37416576 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35416257 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35036987 |

